Literature DB >> 7755151

Neuroendocrine cell hyperplasia and obliterative bronchiolitis in patients with peripheral carcinoid tumors.

R R Miller1, N L Müller.   

Abstract

Specimens from 25 consecutive patients undergoing lung resection for peripheral carcinoid tumor were examined for evidence of neuroendocrine cell hyperplasia and associated obliterative bronchiolitis. Where available, the CT scans (n = 11) were reviewed for evidence of multiple tumors, and pulmonary function data (n = 16) were reviewed for evidence of airflow obstruction. Nineteen of the 25 patients (76%) had neuroendocrine cell hyperplasia in addition to the dominant carcinoid tumor. Eight patients (32%) had lesions of obliterative bronchiolitis associated with foci of neuroendocrine cell hyperplasia, and two of these patients had asymptomatic airflow obstruction that could not be related to smoking or other lung disease. We conclude that multicentric neuroendocrine cell proliferation is common in patients with peripheral carcinoid tumor of the lung. Associated bronchiolar fibrosis occurs in a high proportion of such patients, but it is usually asymptomatic.

Entities:  

Mesh:

Year:  1995        PMID: 7755151     DOI: 10.1097/00000478-199506000-00005

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  24 in total

1.  DIPNECH: Association Between Histopathology and Clinical Presentation.

Authors:  Rocco Trisolini; Ilaria Valentini; Carmine Tinelli; Marco Ferrari; Gian Marco Guiducci; Sergio Nicola Forti Parri; Giorgia Dalpiaz; Alessandra Cancellieri
Journal:  Lung       Date:  2016-02-15       Impact factor: 2.584

Review 2.  Pathogenesis of lung cancer: 100 year report.

Authors:  York E Miller
Journal:  Am J Respir Cell Mol Biol       Date:  2005-09       Impact factor: 6.914

3.  [EGFR-expression in pulmonary neuroendocrine cell hyperplasia].

Authors:  C Kuhnen; B U Winter
Journal:  Pathologe       Date:  2006-03       Impact factor: 1.011

4.  [A 74-year-old female patient with histologically proven carcinoid of the lungs and pulmonary mosaic pattern].

Authors:  B Greiner; C Schulz; M Pfeifer; P Heiss; M Völk; S Feuerbach; O W Hamer
Journal:  Radiologe       Date:  2009-06       Impact factor: 0.635

Review 5.  Pulmonary preinvasive neoplasia.

Authors:  K M Kerr
Journal:  J Clin Pathol       Date:  2001-04       Impact factor: 3.411

Review 6.  Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia of the Lung (DIPNECH): Current Best Evidence.

Authors:  Eric Wirtschafter; Ann E Walts; Sandy T Liu; Alberto M Marchevsky
Journal:  Lung       Date:  2015-06-24       Impact factor: 2.584

7.  Atypical carcinoid localized at the bronchus accompanied by diffuse idiopathic pulmonary neuroendocrine cell hyperplasia in the distal lung: a rare case report.

Authors:  Kyoshiro Takegahara; Akira Sato; Takayuki Ibi; Tatsuya Inoue; Jitsuo Usuda
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

Review 8.  Management of pulmonary neuroendocrine tumors.

Authors:  Robert A Ramirez; Aman Chauhan; Juan Gimenez; Katharine E H Thomas; Ioni Kokodis; Brianne A Voros
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

Review 9.  Fibrosis and carcinoid syndrome: from causation to future therapy.

Authors:  Maralyn Druce; Andrea Rockall; Ashley B Grossman
Journal:  Nat Rev Endocrinol       Date:  2009-05       Impact factor: 43.330

10.  Pulmonary carcinoid tumorlet without underlying lung disease: analysis of its relationship to fibrosis.

Authors:  Ping He; Xia Gu; Qinian Wu; Yunen Lin; Yingying Gu; Jianxing He
Journal:  J Thorac Dis       Date:  2012-12       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.